Frank Karbe
2019
In 2019, Frank Karbe earned a total compensation of $4M as Principal Financial and Accounting Officer at Myovant Sciences Ltd., a 80% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $229,000 |
|---|---|
| Option Awards | $3,068,716 |
| Salary | $436,000 |
| Stock Awards | $285,394 |
| Other | $2,180 |
| Total | $4,021,290 |
Karbe received $3.1M in option awards, accounting for 76% of the total pay in 2019.
Karbe also received $229K in non-equity incentive plan, $436K in salary, $285.4K in stock awards and $2.2K in other compensation.
Rankings
In 2019, Frank Karbe's compensation ranked 2,959th out of 13,971 executives tracked by ExecPay. In other words, Karbe earned more than 78.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,959 out of 13,971 | 79th |
Division Manufacturing | 1,067 out of 5,701 | 81st |
Major group Chemicals And Allied Products | 356 out of 2,200 | 84th |
Industry group Drugs | 291 out of 1,886 | 85th |
Industry Pharmaceutical Preparations | 215 out of 1,398 | 85th |
Source: SEC filing on July 24, 2020.
Karbe's colleagues
We found two more compensation records of executives who worked with Frank Karbe at Myovant Sciences Ltd. in 2019.
News
Myovant Sciences Ltd. Principal Executive Officer David Marek's 2021 pay jumps 154% to $6.2M
July 27, 2022
Myovant Sciences Ltd. Principal Executive Officer Lynn Seely's 2019 pay jumps 40% to $6.2M
July 24, 2020
Myovant Sciences Ltd. Principal Executive Officer Lynn Seely's 2018 pay falls 64% to $4.4M
July 25, 2019